Toward stable N4-modified neurotensins for NTS1-receptor- targeted tumor imaging with99mTc

Journal of Medicinal Chemistry

Volumn 49, Issue 15, 2006, Pages 4767-4776

  Nock, Berthold A ^a   Nikolopoulou, Anastasia ^a   Reubi, Jean Claude ^b   Maes, Veronique ^c   Conrath, Peter ^c   Tourwé, Dirk ^c   Maina, Theodosia ^a  

^a INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

^b UNIVERSITY OF BERN   (Switzerland)

^c VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

DEMOTENSIN[1-4]; NEUROTENSIN; NEUROTENSIN RECEPTOR; NEUROTENSIN RECEPTOR 1; NEUROTENSIN[8-13]; PROTEINASE; TECHNETIUM 99M; UNCLASSIFIED DRUG; DRUG DERIVATIVE; NEUROTENSIN TYPE 1 RECEPTOR; OLIGOPEPTIDE; RADIOPHARMACEUTICAL AGENT; TECHNETIUM COMPLEX;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CELL STRAIN HT29; CONTROLLED STUDY; DIAGNOSTIC IMAGING; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUDE MOUSE; PEPTIDE SYNTHESIS; TUMOR LOCALIZATION; ANIMAL; DRUG STABILITY; FEMALE; IN VITRO STUDY; MALE; METABOLISM; NEOPLASM; PANCREAS CARCINOMA; PANCREAS TUMOR; SCINTISCANNING; STRUCTURE ACTIVITY RELATION; SYNTHESIS; TISSUE DISTRIBUTION; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; CARCINOMA, PANCREATIC DUCTAL; CELL LINE, TUMOR; DRUG STABILITY; FEMALE; HUMANS; MALE; MICE; MICE, NUDE; NEOPLASMS; NEUROTENSIN; OLIGOPEPTIDES; ORGANOTECHNETIUM COMPOUNDS; PANCREATIC NEOPLASMS; RADIOPHARMACEUTICALS; RECEPTORS, NEUROTENSIN; STRUCTURE-ACTIVITY RELATIONSHIP; TISSUE DISTRIBUTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 33746747036     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm060415g     Document Type: Article

References (38)

1. Carraway, R.; Leeman, S. E. The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami. J. Biol. Chem. 1973, 248, 6854-6861.
2. Kitabgi, P.; Carraway, R.; Leeman, S. E. Isolation of a tridecapeptide from bovine intestinal tissue and its partial characterization as neurotensin. J. Biol. Chem. 1976, 251, 7053-7058.
3. Mazella, J.; Amar, S.; Bozou, J. C.; Kitabgi, P.; Vincent, J. P. Functional properties and molecular structure of central and peripheral neurotensin receptors. J. Recept. Res. 1987, 7, 157-165.
4. Vincent, J. P. Neurotensin receptors. Binding properties, transduction mechanisms and purification. Ann. N. Y. Acad. Sci. 1992, 668, 90-100.
5. Vincent, J. P.; Mazella, J.; Kitabgi, P. Neurotensin and neurotensin receptors. Trends Pharmacol. Sci. 1999, 20, 302-309.
6. Reubi, J. C.; Waser, B.; Friess, H.; Buchler, M.; Laissue, J. Neurotensin receptors: a new marker for human ductal pancreatic adenocarcinoma. Gut 1998, 42, 546-550.
7. Wang, L.; Friess, H.; Zhu, Z.; Graber, H.; Zimmermann, A.; Korc, M.; Reubi, J. C.; Büchler, M. W. Neurotensin receptor-1 mRNA analysis in normal pancreas and pancreatic disease. Clin. Cancer Res. 2000, 6, 566-571.
8. Ehlers, R. A.; Kim, S.; Zhang, Y.; Ethridge, R. T.; Murrilo, C.; Hellmich, M. R.; Evans, D. B.; Townsend, C. M. Jr.; Evers, B. M. Gut peptide receptor expression in human pancreatic cancers. Ann. Surg. 2000, 231, 838-848.
9. Reubi, J. C.; Waser, B.; Schaer, J. C.; Laissue, J. A. Neurotensin receptors in human neoplasms: high incidence in Ewing's sarcomas. Int. J. Cancer 1999, 82, 213-218.
10. Maoret, J. J.; Pospaï, D.; Rouyer-Fessard, C.; Couvineau, A.; Laboisse, C.; Voisin, T.; Laburthe, M. Neurotensin receptor and its mRNA are expressed in many human colon cancer cell lines but not in normal colonic epithelium: binding studies and RT-PCR experiments. Biochem. Biophys. Res. Commun. 1994, 203, 465-471.
11. Reubi, J. C. Peptide receptors as molecular targets for cancer diagnosis and therapy. Endocr. Rev. 2003, 24, 389-427.
12. Reubi, J. C.; Waser, B.; Schmassmann, A.; Laissue, J. A. Receptor autoradiographic evaluation of cholecystokinin, neurotensin, somatostatin and vasoactive intestinal peptide receptors in gastrointestinal adenocarcinoma samples: where are they really located? Int. J. Cancer 1999, 81, 376-386.
13. Rettenbacher, M.; Reubi, J. C. Localization and characterization of neuropeptide receptors in human colon. Naunyn-Schmiedebergs Arch. Pharmacol. 2001, 364, 291-304.
14. Reubi, J. C.; Mäcke, H. R.; Krenning, E. P. Candidates for peptide receptor radiotherapy today and in the future. J. Nucl. Med. 2005, 46 (Suppl. 1), 67S-75S.
15. Reubi, J. C.; Horisberger, U.; Essed, C. E.; Jeekel, J.; Klijn, J. G.; Lamberts, S. W. Absence of somatostatin receptors in human exocrine pancreatic adenocarcinomas. Gastroenterology 1988, 95, 760-763.
16. 2 somatostatin receptor gene expression in human pancreatic and colorectal cancer. Cancer Res. 1996, 56, 1823-1827.
17. Ishizuka, J.; Townsend, C. M.; Thomson, J. C. Neurotensin regulates growth of human pancreatic cancer. Ann. Surg. 1993, 217, 439-446.
18. Guha, S.; Rey, O.; Rozengurt, E. Neurotensin induces protein kinase C-dependent protein kinase D activation and DNA synthesis in human pancreatic carcinoma cell line PANC-1. Cancer Res. 2002, 62, 1632-1640.
19. Achilefu, S.; Srinivasan, A.; Schmidt, M. A.; Jimenez, H. N.; Bugaj, J. E.; Erion, J. L. Novel bioactive and stable neurotensin peptide analogues capable of delivering radiopharmaceuticals and molecular beacons to tumors. J. Med. Chem. 2003, 46, 3403-3411.
20. 111In-labeled DTPA- and DOTA-conjugated neurotensin analogues for imaging and therapy of exocrine pancreatic cancer. Eur. J. Nucl. Med. Mol. Imaging 2003, 30, 1134-1139.
21. Schubiger, P. A.; Allemann-Tannahill, L.; Egli, A.; Schibli, R.; Alberto, R.; Carrel-Rémy, N.; Willmann, M.; Bläuenstein, P.; Tourwé, D. Catabolism of neurotensins. Implications for the design of radiolabeling strategies of peptides. Q. J. Nucl. Med. 1999, 43, 155-158.
22. García-Garayoa, E.; Allemann-Tannahill, L.; Bläuenstein, P.; Willmann, M.; Carrel-Rémy, N.; Tourwé, D.; Iterbeke, K.; Conrath, P.; Schubiger, P. A. In vitro and in vivo evaluation of new radiolabeled neurotensin(8-13) analogues with high affinity for NT1 receptors. Nucl. Med. Biol. 2001, 28, 75-84.
23. Brühlmeier, M.; García-Garayoa, E.; Blanc, A.; Holzer, B.; Gergely, S.; Tourwé, D.; Schubiger, P. A.; Bläuenstein, P. Stabilization of neurotensin analogues: effect on peptide catabolism, biodistribution and tumor binding. Nucl. Med. Biol. 2002, 29, 321-327.
24. 99mTc. J. Nucl. Med. 2002, 43, 374-383.
25. 99mTc-labeled neurotensin analogues with optimized biodistribution properties. J. Med. Chem. 2006, 49, 1833-1836.
26. Kitabgi, P., De Nadai, F.; Rovère, C.; Bidard, J. N. Biosynthesis, maturation release and degradation of neurotensin and neuromedin N. Ann. N. Y. Acad. Sci. 1992, 668, 30-42.
27. Davis, T. P.; Konings, P. N. Peptidases in the CNS: formation of biologically active, receptor-specific peptide fragments. Crit. Rev. Neurobiol. 1993, 7, 163-174.
28. Doulut, S.; Rodriguez, M.; Lugrin, D., Vecchini, F.; Kitabgi, P.; Aumelas, A.; Martinez, J. Reduced peptide bond pseudopeptide analogues of neurotensin. Pept. Res. 1992, 5, 30-38.
29. 2NH) pseudopeptide analogues of the C-terminal hexapeptide of neurotensin. Int. J. Pept. Res. 1993, 41, 181-184.
30. 99mTc-NT- XI, evaluated in ductal pancreatic adenocarcinoma patients. J. Nucl. Med. 2003, 44, 1649-1654.
31. 3]octreotate analogue for the detection of somatostatin receptor-positive tumours: synthesis and preclinical results. Eur. J. Nucl. Med. Mol. Imaging 2002, 29, 742-753.
32. 99mTc: a preclinical study. J. Med. Chem. 2005, 48, 100-110.
33. 99mTc-Demotate 1: first data in tumour patients-results of a pilot/phase I study. Eur. J. Nucl. Med. Mol. Imaging 2003, 30, 1211-1219.
34. 99mTc-labeled minigastrin analogs. J. Nucl. Med. 2005, 46, 1727-1736.
35. Bläuenstein, P.; Pfeiffer, G.; Schubiger, P. A.; Anderegg, G.; Zollinger, K.; May, K.; Proso, Z.; Ianovici, E.; Lerch, P. Chemical and biological properties of a cationic Tc-tetraamine complex. Int. J. Appl. Radiat. Isot. 1985, 36, 315-317.
36. Mantegazzi, D.; Ianoz, E.; Lerch, P.; Nicolò, F.; Chapuis, G. Preparation and crystal structure of polymeric lithium[dioxo-Tc(V)- tetraazaundecane]-bis(trifluoromethanesulfonate) complex. Inorg. Chim. Acta 1990, 176, 99-105.
37. +. Inorg. Chem. 1988, 27, 4127-4130.
38. Bidard, J. N.; de Nadai, F.; Rovère, F.; Moinier, D.; Laur, J.; Martinez, J.; Cuber, J. C.; Kitabgi, P. Immunological and biochemical characterization of processing products from the neurotensin/neuromedin N precursor in the rat medullary thyroid carcinoma 6-23 cell line. Biochem. J. 1993, 291, 225-233.